UPC UPC
Company Profile ↓Company Overview
UPC (UPC) is a publicly traded company listed on with a market capitalization of $3.47M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Carries low leverage with a debt-to-equity ratio of 0.16.
Recent Developments
- Sep 2025 Revenue of $17.86M (-22.4% YoY); net profit $-3.67M.
- Trailing 12 Months Year-on-year growth — revenue -22.4%.
- 5-Year Trend Long-term compounding — revenue CAGR -23.7%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | -23.66% |
| 1 Year: | -22.44% |
Stock Price Performance
| 1 Year: | +75.00% |
| 6 Months: | +35.98% |
| 3 Months: | +100.65% |
| 1 Month: | -2.53% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)59.36 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Revenue declined at -23.7% CAGR over 5 years.
- Trading 49.4% below its 52-week high.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Profit & Loss (Annual)
Figures in USD.
| Metric | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|---|
| Revenue | - | 40.14M | 32.31M | 23.02M | 17.86M |
| Cost of Revenue | - | 18.25M | 21.99M | 16.95M | 11.56M |
| Gross Profit | - | 21.89M | 10.32M | 6.07M | 6.30M |
| Operating Expenses | - | 28.91M | 14.28M | 14.09M | 9.22M |
| Operating Income | - | -7.02M | -3.97M | -8.02M | -2.92M |
| EBITDA | - | -6.40M | -3.66M | -7.36M | -2.92M |
| Interest Expense | - | 162.40K | 156.79K | 278.17K | 232.04K |
| Pretax Income | - | -7.09M | -4.33M | -8.12M | -3.67M |
| Tax Provision | - | 815.32K | 2.25M | 606.70K | 0 |
| Net Income | - | -7.91M | -6.58M | -8.73M | -3.67M |
| Diluted EPS | 2,520.00 | -1,335.29 | -1,089.21 | -626.96 | - |
Balance Sheet (Annual)
Figures in USD.
| Metric | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 59.54M | 41.72M | 67.95M | 69.30M |
| Current Assets | - | 41.51M | 25.27M | 51.64M | 53.60M |
| Cash & Equivalents | - | 5.71M | 5.29M | 29.50M | 33.59M |
| Inventory | - | 2.21M | 3.34M | 1.74M | 2.19M |
| Receivables | - | 15.18M | 11.01M | 12.91M | 13.01M |
| Total Liabilities | - | 13.10M | 13.75M | 22.45M | 13.17M |
| Current Liabilities | - | 13.10M | 13.75M | 20.31M | 13.17M |
| Long Term Debt | - | - | - | 2.14M | - |
| Total Debt | - | 3.94M | 5.48M | 7.99M | 9.26M |
| Total Equity | - | 46.44M | 27.97M | 45.50M | 56.13M |
| Shares Outstanding | - | 6.04K | 6.08K | 39.41K | 563.34K |
Cash Flows (Annual)
Figures in USD.
| Metric | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | -1.30M | 1.12M | -9.51M | -5.05M |
| Investing Cash Flow | - | -3.91M | -44.17K | -361.29K | -341.81K |
| Financing Cash Flow | - | 3.32M | -1.39M | 33.95M | 9.73M |
| Capital Expenditure | - | -93.70K | -44.17K | -363.09K | -347.19K |
| Free Cash Flow | - | -1.40M | 1.07M | -9.87M | -5.40M |
| Net Change in Cash | - | -1.89M | -318.04K | 24.09M | 4.33M |
Ratios (Annual)
Figures in %.
| Metric | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 54.5% | 31.9% | 26.4% | 35.3% |
| Operating Margin % | - | -17.5% | -12.3% | -34.8% | -16.3% |
| Net Margin % | - | -19.7% | -20.4% | -37.9% | -20.6% |
| ROE % | - | -17.0% | -23.5% | -19.2% | -6.5% |
| ROCE % | - | -15.1% | -14.2% | -16.8% | -5.2% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for UPC
UPC Stock Surges 288% After Hours — What’s Driving The Rally?
Universe Pharmaceuticals agreed to buy 100% of Best Praise International Limited, a company that holds five patents in China.
Universe Pharmaceuticals INC Announces Strategic Acquisition to Expand Pharmaceutical Patent Portfolio
Ji'an, Jiangxi, China, June 26, 2026 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (NASDAQ: UPC) (“Universe Pharmaceuticals” or the “Company”), a pharmaceutical producer and distributor in China, today announced that the Company has ente…
Universe Pharmaceuticals INC Announces Effective Date of Dual-Class Share Structure
Ji'an, Jiangxi, China, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (NASDAQ: UPC) (“Universe Pharmaceuticals” or the “Company”), a pharmaceutical producer and distributor in China, today announced that all conditions to th…
UPC — Frequently Asked Questions
What is the current share price of UPC?
As of 2026-08-05 17:25 PDT, UPC trades at $6.16 on NASDAQ/NYSE. Its 52-week range is $2.25 to $12.18.
What is the market capitalisation of UPC?
UPC has a market capitalisation of $3.47M on NASDAQ/NYSE.
What is the P/E ratio of UPC?
UPC trades at a trailing price-to-earnings (P/E) ratio of -0.01. Its price-to-book (P/B) ratio is 0.06.
What is the return on equity (ROE) of UPC?
UPC has a return on equity (ROE) of -6.54%. Its return on capital employed (ROCE) is -5.19%.
Is UPC a good stock to buy?
This page provides a data-driven analysis of UPC, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.